Sample Grants Given
NEURO TRIALS LLC
MULTIPLE AWARDS:1) DEVELOPMENT FO TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA.2) UCSF PRECLINICAL CORE FOR DRUG DEVELOPMENT AT THE IVY BRAIN TUMOR CENTER.3)10 YEAR IBTC GRANT4) MATCHING FUNDS NATIONAL GBM DAY
$4,317,325
STANFORD UNIVERSITY
YEAR 1 OF 3 YEAR AWARD: IMAGING TUMOR METABOLISM IN GBM PATIENTS TO HELP OPTIMIZE ANTI-TUMOR THERAPIES. THE ABILITY TO MONITOR PKM2, A KEY REGULATOR OF GBM METABOLISM, ALLOWS POTENIAL MONITORING ESSENTIAL TO EARLY THERAPY RESPONSE.
$1,024,920
CITY OF HOPE MEDICAL CENTER
YEAR 2 OF 3 YEAR AWARD:ENGINEERING DE NOVO ANTITUMOR IMMUNITY USING PATIENT-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS. DEVELOPMENT OF A NEW CLASS OF CARS EXPLOITING THE BROAD AND SELECTIVE GBM BINDING PROPERTIES OF THE SCORPION TOXIN PEPTIDE CHLOROTOXIN (CTX) AND EVALUATE THE POTENTIAL OF A CTX-CAR TO LIMIT GBM ANTIGEN ESCAPE.
$957,527
MAYO CLINIC
YEAR 4 OF 4 YEAR AWARD:AIM TO DRIVE CLINICAL DISCOVERY THROUGH OPTIMIZED MATHEMATICAL NEURO-ONCOLOGY RESPONSE METRICS BY CONNECTING PATIENT-SPECIFIC TREATMENT RESPONSE TO PATIENT SPECIFIC BENEFIT.
$500,000
SWEDISH MEDICAL CENTER
FINAL PAYMENT THERAPEUTIC TARGETING OF MICROENVIRONMENTS WHICH WILL LEVERAGE THE IVY GLIOBLASTOMA ATLAS PROJECT TO IDENTIFY CANCER STEM CELL AND IMMUNE CELL COMPARTMENTS AND TO FUNCTIONALLY CHARACTERIZE AND TARGET THE CELLS IN THE CONTEXT OF THEIR MICROENVIRONMENTS.
$413,000
Showing up to 5 of 20 total records — full history available with membership.